Premium
It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest in the drugmaker hasn’t dampened much.Earlier this month, US-based investment firm Capital International acquired a 3% stake in the Ahmedabad-based company from homegrown PE firm ChrysCapital for Rs 690 crore ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
